Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-30

Clinical Trial Update: The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients [NA]

View source ↗

Summary

A clinical trial evaluating the effect of acetaminophen on patients with non-alcoholic fatty liver disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen (Acetaminophen)

Snippet

Sponsor: University of Southern California | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD) | NA | Status: WITHDRAWN